Abstract Details
|
Alexander T. Scott, Research coordinator
PRESENTER |
Mr. Scott has nothing to disclose. |
| Rebecca Stafford (Boston Medical Center) | Ms. Stafford has nothing to disclose. |
| Isabelle Xu, BA | Miss Xu has nothing to disclose. |
| Ali Daneshmand, MD (Boston University School of Medicine) | Dr. Daneshmand has nothing to disclose. |
| Brian J. Coffey, MD | Dr. Coffey has nothing to disclose. |
| Ika Noviawaty, MD (Boston Medical Center) | Dr. Noviawaty has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz Pharmaceutical/CME Outfitter. The institution of Dr. Noviawaty has received research support from MARINUS. The institution of Dr. Noviawaty has received research support from UCB. |
| David M. Greer, MD, FAAN (Boston University School of Medicine) | Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. An immediate family member of Dr. Greer has or had stock in Vertex Pharmaceuticals. The institution of Dr. Greer has received research support from NINDS. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities. |